Workflow
Lineage, Inc.(LINE)
icon
搜索文档
LINE LAWSUIT ALERT: Lineage, Inc. Hit with Securities Class Action after 17% Stock Drop – Investors Urged to Contact BFA Law
Globenewswire· 2025-09-10 19:07
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit. Investors have until September 30, 2025, to ask the Court to ...
LINE LAWSUIT ALERT: Levi & Korsinsky Notifies Lineage, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Prnewswire· 2025-09-09 21:00
Accessibility StatementSkip Navigation NEW YORK, Sept. 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with t ...
LINE NOTICE: Lineage, Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit
Globenewswire· 2025-09-09 05:26
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ:LINE) investors of the September 30, 2025 to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Lineage securities between July 22, 2024 through August 1, 2025 (“the Class Period”). Follow the link below for more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened? On April 30, 2025, Lineage reported first quar ...
Levi & Korsinsky Notifies Lineage, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – LINE
Globenewswire· 2025-09-09 04:17
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lineage, Inc. ("Lineage, Inc." or the "Company") (NASDAQ: LINE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lineage, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all purchasers of Lineage common stock in or traceable to the registration statement used in connection with the Company’s July 26, 2024 initial ...
LINEAGE, INC. (NASDAQ: LINE) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Lineage, Inc. Investors of Upcoming Deadline
Globenewswire· 2025-09-08 22:16
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Lineage, Inc. (NASDAQ: LINE)?Did you purchase your shares in, or traceable to, the Company’s July 2024 IPO?Did you lose money in your in ...
LINE SHAREHOLDERS: Lineage, Inc. Downturn Triggers Class Action -- Contact BFA Law by September 30 if You Lost Money (NASDAQ:LINE)
Globenewswire· 2025-09-08 20:36
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Lineage, Inc. (NASDAQ: LINE) and certain of the Company’s senior executives and directors for potential violations of the federal securities laws. If you invested in Lineage, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/lineage-inc-class-action-lawsuit. Investors have until September 30, 2025, to ask the Court to ...
Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes
Businesswire· 2025-09-08 20:00
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf†, cell therapies for serious medical conditions, today announced the initiation of a new islet cell transplant program in Type 1 Diabetes (T1D). Specifically, the company aims to deploy its manufacturing capability to address the issue of large-scale production of islet cells, with the ini ...
Lineage, Inc. (NASDAQ: LINE) Faces Legal Challenges Amidst Revised Price Targets
Financial Modeling Prep· 2025-09-08 19:00
Scotiabank analyst Greg McGinniss sets a new price target of $43 for NASDAQ:LINE, indicating a potential upside of 5.94%.The stock's volatility is highlighted by its year-long fluctuation between $84.86 and $38.83.Rosen Law Firm encourages investors to seek legal counsel ahead of a lead plaintiff deadline, potentially affecting investor sentiment and stock performance.Lineage, Inc. (NASDAQ: LINE) is a company that has recently caught the attention of investors and analysts alike. On September 5, 2025, Greg ...
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Lineage, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LINE
GlobeNewswire News Room· 2025-09-08 02:15
公司运营状况 - 公司客户需求持续疲软 因额外冷库供应上线且客户正在清理COVID-19疫情期间积累的过剩库存[5] - 客户转向维持更精简的冷库库存以应对消费趋势变化[5] - 公司在IPO前实施了不可持续的价格上调[5] - 公司无法通过最低存储保证、运营效率或技术改进有效抵消不利趋势[5] 财务表现 - 公司收入出现停滞或下降 与注册声明中承诺的稳定增长相反[5] - 公司 occupancy rates(占用率)和租金价格出现下降[5] - 公司财务业绩、业务运营和前景受到实质性损害[5] 法律诉讼 - 针对公司IPO注册声明提起集体诉讼 指控其存在虚假和/或误导性陈述[1][5] - 诉讼称注册声明未披露客户需求疲软、价格不可持续及财务表现恶化等关键事实[5] - 投资者可在2025年9月30日前申请成为首席原告[1][3]